US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,834.82

+26.851.49%

Number of Gainers:8

Number of Losers:11

Number of Flat:- -

PE:- -

High:1,846.22

Open:1,807.96

Low:1,807.96

Close:1,807.97

Volume:94.07M

Turnover:7.41B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

AstraZeneca completes $2B equity investment in Summit Therapeutics

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Nurix Extends Gilead Collaboration for Oncology Program

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS

Pfizer (PFE) Quietly Builds New Cancer And RSV Powerhouse

ADPT, MRNA, CRWV, NBIS, JAZZ trending with analysts

Pfizer (PFE) Receives a Hold from Leerink Partners

Novavax Inc. Stock Underperforms Friday When Compared to Competitors

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

BioNTech CEO Uğur Şahin Disposes of $3,304,076 in Common Shares

Pfizer Says Litfulo Safety Profile in NSV Consistent with Alopecia Areata

Sector Update: Healthcare

MT Newswires Live

Pfizer Tilrekimig Data Support TSLP Role in Atopic Dermatitis, UBS Says

MT Newswires Live

Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Pfizer Says Phase 3 Trials Show Litfulo Improves Repigmentation in Nonsegmental Vitiligo Patients at Week 52

Pfizer - to Submit Litfulo Phase 3 Data to FDA and Ema

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4568/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1834.8213,"timestamp":1791403199999,"preClose":1807.9673,"halted":0,"volume":94070954,"delay":0,"changeRate":0.014853,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":26.854004,"latestTime":"10-07 16:00:00 EDT","open":1807.9589,"high":1846.2249,"low":1807.9589,"amount":7413625263.41385,"amplitude":0.021165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.738387,"peRate":45.966788,"turnoverRate":0.00678,"increases":8,"decrements":11,"flats":0,"marketCap":1491961574063,"floatMarketCap":1456681952673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1846.2249,"amplitude":0.021165,"preClose":1807.9673,"low":1807.9589,"pbRate":"4.738387","latestPrice":1834.8213,"volume":94070954,"delay":0,"open":1807.9589,"prevYearClose":1637.1339,"prevWeekClose":1811.1105,"prevMonthClose":1862.664,"prevQuarterClose":1862.664,"fiveDayClose":1862.664,"twentyDayClose":1835.2891,"sixtyDayClose":1685.2764,"secType":"PLATE","market":"US","turnoverRate":0.00678,"peRate":45.966788,"marketCap":1491961574063,"floatMarketCap":1456681952673,"timestamp":1791403199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673044487","title":"AstraZeneca completes $2B equity investment in Summit Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044487","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:12","pubTimestamp":1791198767,"startTime":"0","endTime":"0","summary":"Summit Therapeutics (SMMT) announced the successful closing of AstraZeneca’s (AZN) strategic equity investment in Summit. The equity investment wil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-2b-equity-investment-in-summit-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-2b-equity-investment-in-summit-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZN","LU2237443622.USD","LU2089984988.USD","BK4139","LU1829250122.USD","LU0320765992.SGD","LU2462157665.USD","LU2237443382.USD","LU2468319806.SGD","SMMT","BK4588","LU0058720904.USD","LU0289739699.SGD","LU2237443465.HKD","LU2237443549.SGD","LU1267930573.SGD","AZNH","LU0029864427.USD","LU2488822045.USD","BK4585","LU0432979614.USD","LU2237443895.HKD","LU0109394709.USD","LU0889565916.HKD","LU2236285917.USD","LU2417539215.USD","LU2456880835.USD","IE00B3T34201.USD","LU2237443978.SGD","LU0708994859.HKD","BK4568","BK4007","LU0128525929.USD","LU0310800379.SGD","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704303","title":"Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704303","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704303?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198202,"startTime":"0","endTime":"0","summary":"Nurix, Gilead extend research term for oncology program by two years for $10 million feeNurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaborat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL7nTmpm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU0965509101.SGD","SG9999015945.SGD","LU2087621335.USD","TBXU","LU2468319806.SGD","GILD","LU0965509010.AUD","NRIX","SG9999015986.USD","BK4583","LU1057294990.SGD","LU1430594728.SGD","IE00BQXX3D17.EUR","LU1934455277.USD","TMED","SG9999014021.USD","BMED","IE0002270589.USD","IE00BQXX3F31.USD","BK4568","BK4585","LU0859254822.USD","LU2210150020.SGD","BK4112","LU0882574055.USD","IBBQ","LU1934455194.USD","BIB","IE00BN0W2W23.USD","BK4578","LU0289739699.SGD","SG9999015978.USD","LU0861579265.USD","IE00B3T34201.USD","NDAQ","IBB","LU0058720904.USD","LU0314104364.USD","BCDF","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1037948897.HKD","MEDI","BBH","BK4566","LU0965509283.SGD","LU0320765992.SGD","LU1839511570.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704306","title":"Nurix Extends Gilead Collaboration for Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704306","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704306?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198199,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Extends Gilead Collaboration For Oncology ProgramOct 5 (Reuters)-Nurix Therapeutics, Inc.NRIX.O:NURIX THERAPEUTICS ANNOUNCES SECOND RESEARCH TERM EXTENSION FOR ONCOLOGY PROGRAM UNDER COLLA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","LU1839511570.USD","TBXU","LU2468319806.SGD","IE00B7SZLL34.SGD","NRIX","IE00B19Z3B42.SGD","IBB","IE00BSNM7G36.USD","LU0058720904.USD","LU2324357040.USD","LU0320765992.SGD","LU1934455194.USD","BK4566","BBH","LU0882574055.USD","SG9999015952.SGD","LU0965508806.USD","LU0965509010.AUD","IE00B3T34201.USD","BK4550","IE00BKVL7J92.USD","LU1037948897.HKD","SG9999015978.USD","LU1585245621.USD","LU0109394709.USD","BK4139","BK4568","BMED","LU1023059063.AUD","LU2089984988.USD","LU1934455277.USD","LU2087621335.USD","IE0002270589.USD","LU0122379950.USD","LU1571399168.USD","IBBQ","LU0861579265.USD","LU0965509283.SGD","LU1066053197.SGD","LU1057294990.SGD","LU2357627491.SGD","LU1934455863.HKD","MEDI","LU0859254822.USD","TMED","SG9999015945.SGD","BIB","LU1674673691.USD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704828","title":"Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704828?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0058720904.USD","LU1037948897.HKD","BBH","LU0234570918.USD","IE00BKVL7J92.USD","TMED","LU0965509283.SGD","NRIX","BK4566","BK4550","LU1934455277.USD","LU1839511570.USD","LU0122379950.USD","LU0823416689.USD","SG9999015978.USD","LU1934455194.USD","LU2324357040.USD","LU2112291526.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4588","IE00B3T34201.USD","IBB","IE00B7SZLL34.SGD","BK4585","IE00B19Z3B42.SGD","BK4139","TBXU","IBBQ","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4532","LU0859254822.USD","MEDI","LU1585245621.USD","BK4568","BMED","LU1571399168.USD","BK4583","LU1778281490.HKD","LU0861579265.USD","LU0882574055.USD","LU0320765992.SGD","BK4578","LU1023059063.AUD","BIB","LU2089984988.USD","GILD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048487","title":"Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015986.USD","BIB","IE00B3T34201.USD","LU0889565916.HKD","LU1066053197.SGD","LU1934455863.HKD","BMED","LU1023059063.AUD","LU0122379950.USD","LU0823416689.USD","MEDI","LU0859254822.USD","LU0965509010.AUD","LU2468319806.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU2087621335.USD","LU1839511570.USD","NRIX","LU1037948541.HKD","IE00B19Z3B42.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD","TMED","BK4568","LU1057294990.SGD","LU1571399168.USD","BK4550","GILD","LU1778281490.HKD","LU1066051498.USD","LU0861579265.USD","LU0320765992.SGD","LU0234570918.USD","SG9999015945.SGD","LU1934455194.USD","IE00B19Z3581.USD","LU2089984988.USD","BBH","IBBQ","LU1674673428.USD","IE00BKVL7J92.USD","LU1037948897.HKD","LU0965509283.SGD","BK4566","IBB","TBXU","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048127","title":"Nurix - to Receive $10 Mln Research Term Extension Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048127?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","TMED","LU1037948897.HKD","SG9999015945.SGD","BK4566","IE0002270589.USD","LU1430594728.SGD","LU1934455194.USD","LU2087621335.USD","SG9999015952.SGD","LU0320765992.SGD","IBB","LU0965509101.SGD","LU1037948541.HKD","LU0861579265.USD","LU0965509283.SGD","MEDI","IE00BKVL7J92.USD","SG9999015986.USD","LU1023059063.AUD","LU2468319806.SGD","TBXU","LU2089984988.USD","BMED","LU1571399168.USD","IBBQ","BK4550","LU1934455863.HKD","LU0122379950.USD","LU1066051498.USD","BIB","IE00BSNM7G36.USD","LU1674673428.USD","LU0289739699.SGD","BK4568","IE00B19Z3581.USD","LU0234570918.USD","LU0965509010.AUD","LU1066053197.SGD","LU0823416689.USD","LU1839511570.USD","LU1778281490.HKD","LU0859254822.USD","BBH","IE00B3T34201.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","GILD","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021701","title":"Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU1778281490.HKD","LU1839511570.USD","BK4532","BK4568","LU0109394709.USD","LU1057294990.SGD","LU1934455277.USD","LU2087621335.USD","LU0889565916.HKD","BMED","LU0965509010.AUD","LU1571399168.USD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU0058720904.USD","SG9999015945.SGD","LU0861579265.USD","TMED","LU1066053197.SGD","LU1066051498.USD","IE00BSNM7G36.USD","BBH","SG9999015986.USD","IBB","BIB","IE0002270589.USD","IBBQ","LU1037948541.HKD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1037948897.HKD","TBXU","LU0882574055.USD","LU1934455194.USD","MEDI","BK4585","LU1430594728.SGD","LU0859254822.USD","LU0965509101.SGD","BK4578","SG9999015978.USD","NRIX","IE00B3T34201.USD","GILD","LU1061106388.HKD","BK4566","IE00B19Z3B42.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672726308","title":"Pfizer (PFE) Quietly Builds New Cancer And RSV Powerhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2672726308","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672726308?lang=en_us&edition=fundamental","pubTime":"2026-10-03 23:02","pubTimestamp":1791039728,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is pushing deeper into onc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-pfe-quietly-builds-new-cancer-and-rsv-powerhouse?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-pfe-quietly-builds-new-cancer-and-rsv-powerhouse?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0170899867.USD","LU0456855351.SGD","BK4592","LU1894683348.USD","BK4533","BK4534","SG9999013999.USD","SG9999002232.USD","BK4550","PFE","LU1057294990.SGD","LU1894683264.USD","LU0868494617.USD","LU1066053197.SGD","BK4585","BK4007","OZEM","BK4581","LU0321505439.SGD","LU0306807586.USD","LU0321505868.SGD","LU0985481810.HKD","SG9999003800.SGD","LU0234572021.USD","LU0289739699.SGD","IE00BBT3K403.USD","LU0122379950.USD","IE00B19Z3581.USD","IE0002270589.USD","IE00B3T34201.USD","SG9999001176.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU2596442595.SGD","LU0225771236.USD","LU1066051498.USD","BK4588","BK4568","SG9999001176.USD","LU1883839398.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU0306806265.USD","SG9999002224.SGD","IE000M9KFDE8.USD","BK4599","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672728212","title":"ADPT, MRNA, CRWV, NBIS, JAZZ trending with analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2672728212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672728212?lang=en_us&edition=fundamental","pubTime":"2026-10-03 17:01","pubTimestamp":1791018089,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($ADPT) ), ( ($MRNA) ), ( ($CRWV) ), ( ($NBIS) ) and ( ($JAZZ) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/adpt-mrna-crwv-nbis-jazz-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/adpt-mrna-crwv-nbis-jazz-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4121","LU0823416689.USD","WDNA","BK4532","LU0320765992.SGD","BK4533","IDNA","LU0109394709.USD","BK4501","ADPT","LGHT","BK4007","JAZZ","MRNX","BK4568","IE00BN0W2T93.GBP","MRNA","BK4551","BK4534","BK4585","LU0154245756.USD","BK4588","BK4548","BK4139","IE00BN0W2W23.USD","HELX","GNOM","MRNY","IE00BN0W2V16.EUR","LU0154245673.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672747749","title":"Pfizer (PFE) Receives a Hold from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2672747749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672747749?lang=en_us&edition=fundamental","pubTime":"2026-10-03 12:25","pubTimestamp":1791001557,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Leerink Partners maintained a Hold rating on Pfizer. The company’s shares closed yesterday at $27.80. Currentl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pfizer-pfe-receives-a-hold-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pfizer-pfe-receives-a-hold-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225771236.USD","LU0985481810.HKD","BK4581","BK4534","LU0225284248.USD","SG9999003800.SGD","IE00B3T34201.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0306807586.USD","IE00BBT3K403.USD","BK4592","SG9999011175.SGD","BK4550","PFE","IE0002270589.USD","LU0456855351.SGD","LU0321505868.SGD","BK4588","IE00B19Z3B42.SGD","SG9999002224.SGD","LU1883839398.USD","LU2596442595.SGD","BK4599","OZEM","LU0170899867.USD","LU0122379950.USD","LU0868494617.USD","LU1066053197.SGD","BK4007","LU0289739699.SGD","LU0306806265.USD","LU1057294990.SGD","LU1066051498.USD","BK4568","IE00BLSP4452.SGD","LU1894683348.USD","BK4533","BK4585","LU0234572021.USD","SG9999001176.SGD","SG9999001176.USD","SG9999002232.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU0321505439.SGD","LU1894683264.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741679","title":"Novavax Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741679?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:29","pubTimestamp":1790976540,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 1.32% to $10.46 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.19% to 27,190.86 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's third consecutive day of losses.Novavax Inc. closed 12.61% below its 52-week high of $11.97, which the company reached on February 26th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and Merck & Co. Inc.  rose 0.34% to $144.30.Trading volume  remained 754,335 below its 50-day average volume of 4.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4139","BK4568","NVAX","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749136","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:35","pubTimestamp":1790973300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 1.87% to $144.74 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's fourth consecutive day of losses.Gilead Sciences Inc. closed 7.98% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and Abbott Laboratories  rose 0.84% to $97.50.Trading volume  remained 1.3 million below its 50-day average volume of 6.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4139","LU0114720955.EUR","LU1571399168.USD","LU1934455277.USD","TMED","LU2468319806.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU2087621335.USD","LU2089984988.USD","BK4585","SG9999015978.USD","LU0882574055.USD","LU1934455863.HKD","IBBQ","BK4532","LU0965508806.USD","IE00B3T34201.USD","LU1839511570.USD","BK4568","LU0289739699.SGD","MEDI","LU0058720904.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","LU0122379950.USD","BK4566","LU0889565916.HKD","LU2112291526.USD","LU1037948541.HKD","BK4588","LU1037948897.HKD","BMED","IE00B19Z3B42.SGD","LU0965509101.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1430594728.SGD","LU0859254822.USD","IBB","LU0823416689.USD","LU0965509283.SGD","LU1066051498.USD","LU1674673428.USD","LU2324357040.USD","SG9999015945.SGD","BK4583","LU2357627491.SGD","LU0109394709.USD","SG9999015986.USD","BK4578","BK4550","LU1585245621.USD","LU1061106388.HKD","LU1778281490.HKD","LU0861579265.USD","LU1066053197.SGD","LU1934455194.USD","IE0002270589.USD","SG9999015952.SGD","LU1023059063.AUD","GILD","IE00B19Z3581.USD","TBXU","BBH","BIB","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672541749","title":"BioNTech CEO Uğur Şahin Disposes of $3,304,076 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672541749","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672541749?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:28","pubTimestamp":1790972913,"startTime":"0","endTime":"0","summary":"BioNTech CEO Uur ahin disposes of $3,304,076 in common sharesBioNTech CEO Ugur Sahin sold 34,000 ordinary shares on Oct. 1-2, according to a Form 4 filing.Sales priced at USD 97.4556 on Oct. 1, USD 96","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLbDVdQt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioNTech CEO Uğur Şahin Disposes of $3,304,076 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4551","BK4585","BK4139","BK4568","BK4548","BK4535","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672453137","title":"Pfizer Says Litfulo Safety Profile in NSV Consistent with Alopecia Areata","url":"https://stock-news.laohu8.com/highlight/detail?id=2672453137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672453137?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:24","pubTimestamp":1790961886,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Says Litfulo Safety Profile In NSV Consistent With Alopecia AreataOct 2 (Reuters)-Pfizer Inc.PFE.N:PFIZER’S LITFULO SIGNIFICANTLY IMPROVED FACIAL AND TOTAL BODY REPIGMENTATION IN PATIENTS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0234572021.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999002232.USD","BK4550","SG9999013999.USD","LU1057294990.SGD","SG9999011175.SGD","SGXZ57979304.SGD","LU0321505439.SGD","LU1883839398.USD","LU1066053197.SGD","LU0985481810.HKD","BK4592","BK4599","BK4007","IE0002270589.USD","LU0868494617.USD","BK4568","BK4533","BK4585","LU0306806265.USD","LU1894683264.USD","LU0289739699.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0321505868.SGD","LU0306807586.USD","LU0122379950.USD","SG9999001176.USD","IE00B3T34201.USD","LU1023059063.AUD","LU1894683348.USD","BK4534","LU0225771236.USD","LU0225284248.USD","LU0456855351.SGD","LU0058720904.USD","OZEM","BK4588","LU1066051498.USD","SG9999001176.SGD","LU2596442595.SGD","PFE","BK4581","LU0170899867.USD","SG9999003800.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672745865","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672745865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672745865?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:14","pubTimestamp":1790961293,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index easing 0.1% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.3%.The iShares Biotechnology ETF  was shedding 0.7%.In corporate news, AstraZeneca  and Japan's Daiichi Sankyo have partnered with Summit Therapeutics  to test their drug Datroway plus ivonescimab to treat lung, breast, and other cancers, the companies said Friday. AstraZeneca shares were down 0.7%, and Summit rose 0.7%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU2237443549.SGD","AZN","BK4007","LU2488822045.USD","XBI","LU2237443895.HKD","LU2468319806.SGD","IBB","LU0109394709.USD","BK4581","LU0128526141.USD","LU1267930573.SGD","LU0889565916.HKD","LU0320765992.SGD","LU2089984988.USD","AZNH","BK4585","BK4568","HCSG","LU0708994859.HKD","LU2462157665.USD","LU0128525929.USD","LU2236285917.USD","LU2237443622.USD","LU1829250122.USD","LU2417539215.USD","XLV","LU2237443465.HKD","SMMT","LU2237443382.USD","LU0289739699.SGD","IE00B3T34201.USD","LU2456880835.USD","LU2237443978.SGD","BK4139","LU0432979614.USD","LU0029864427.USD","LU0058720904.USD","LU0029874061.USD","LABU","BK4137","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672235743","title":"Pfizer Tilrekimig Data Support TSLP Role in Atopic Dermatitis, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672235743","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672235743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:54","pubTimestamp":1790960085,"startTime":"0","endTime":"0","summary":"Pfizer's  phase II data for its monthly IL-4, IL-13 and TSLP drug tilrekimig showed placebo-adjusted EASI-75 responses of about 40% to 50%, supporting the potential benefit of adding TSLP inhibition in atopic dermatitis, UBS Securities said.The investment firm said in a note Thursday that the results appear competitive with next-generation agents and above Dupixent on a placebo-adjusted EASI-75 basis.The firm also noted low rates of eye-related adverse events and consistent trends in itch reduction, while the study's placebo response was lower than in some comparable trials.Pfizer has started phase III studies of tilrekimig in asthma and atopic dermatitis, including a head-to-head study against Dupixent. The program could become a meaningful commercial player if successful, according to the note.UBS has a neutral rating on the company's stock, with a $27 price target.Shares of Pfizer were down 2% in Friday afternoon trading.Price: 27.55, Change: -0.57, Percent Change: -2.04","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0321505439.SGD","BK4581","BK4568","LU0456855351.SGD","LU0985481810.HKD","LU0225771236.USD","OZEM","LU1066051498.USD","PFE","SG9999011175.SGD","SG9999001176.SGD","LU1894683348.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","BK4588","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4534","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1894683264.USD","BK4550","LU0234572021.USD","LU0122379950.USD","LU0306806265.USD","LU1883839398.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0868494617.USD","SG9999013999.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672156743","title":"Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2672156743","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672156743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958630,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has updated results from its TACTIVE-U Sub-Study C, a Phas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-tactive-u-breast-cancer-combo-trial-reaches-key-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-tactive-u-breast-cancer-combo-trial-reaches-key-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066053197.SGD","BK4534","LU0868494617.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU1057294990.SGD","SG9999011175.SGD","SG9999001176.SGD","BK4599","BK4581","IE00B3T34201.USD","BK4568","SG9999002224.SGD","BK4588","IE00B19Z3B42.SGD","LU0306807586.USD","BK4533","LU1023059063.AUD","IE0002270589.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU0456855351.SGD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","LU1894683348.USD","PFE","LU1883839398.USD","LU0170899867.USD","SG9999001176.USD","LU0122379950.USD","SG9999013999.USD","BK4550","IE00BLSP4452.SGD","LU1894683264.USD","LU0289739699.SGD","LU0306806265.USD","LU0321505439.SGD","BK4007","LU0321505868.SGD","IE00BBT3K403.USD","LU0985481810.HKD","LU2596442595.SGD","OZEM","LU0234572021.USD","SG9999002232.USD","IE00B19Z3581.USD","LU0225284248.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174809","title":"AstraZeneca PLC Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174809","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174809?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:01","pubTimestamp":1790956860,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC shed 1.6% to SEK1,574.00 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.1% to 2,596.93.This was the stock's fourth consecutive day of losses.The company closed SEK351.50 short of its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 386,423, compared to the 50-day average trading volume of 633,220.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2237443622.USD","LU2237443382.USD","LU2417539215.USD","AZN","LU2089984988.USD","LU0889565916.HKD","LU0320765992.SGD","LU0029864427.USD","LU0310800379.SGD","LU0128525929.USD","LU2462157665.USD","LU0289739699.SGD","LU0432979614.USD","BK4568","BK4007","LU0708994859.HKD","LU2237443549.SGD","LU2237443895.HKD","IE00B3T34201.USD","LU2237443978.SGD","LU2236285917.USD","LU2237443465.HKD","LU1267930573.SGD","LU0109394709.USD","AZNH","BK4588","LU2468319806.SGD","LU1829250122.USD","LU0058720904.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672377748","title":"Pfizer Says Phase 3 Trials Show Litfulo Improves Repigmentation in Nonsegmental Vitiligo Patients at Week 52","url":"https://stock-news.laohu8.com/highlight/detail?id=2672377748","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672377748?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954142,"startTime":"0","endTime":"0","summary":"Pfizer says Phase 3 trials show LITFULO improves repigmentation in nonsegmental vitiligo patients at Week 52Pfizer presented Phase 3 results showing LITFULO improved facial repigmentation and overall ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6gVNgg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","BK4581","BK4568","LU0456855351.SGD","LU0985481810.HKD","LU0225771236.USD","OZEM","LU1066051498.USD","PFE","SG9999011175.SGD","SG9999001176.SGD","LU1894683348.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","BK4588","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4534","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1894683264.USD","BK4550","LU0234572021.USD","LU0122379950.USD","LU0306806265.USD","LU1883839398.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0868494617.USD","SG9999013999.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748319","title":"Pfizer - to Submit Litfulo Phase 3 Data to FDA and Ema","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748319?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954105,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999003800.SGD","BK4550","IE00BBT3K403.USD","IE00B19Z3B42.SGD","LU0321505439.SGD","LU1066053197.SGD","BK4585","LU0122379950.USD","LU0985481810.HKD","BK4588","LU0234572021.USD","LU0306806265.USD","LU2596442595.SGD","BK4533","LU0225771236.USD","LU0170899867.USD","BK4534","LU1057294990.SGD","SG9999002224.SGD","SGXZ57979304.SGD","LU0306807586.USD","BK4007","BK4581","LU1066051498.USD","LU0058720904.USD","BK4568","IE00B19Z3581.USD","LU1023059063.AUD","SG9999013999.USD","BK4592","PFE","OZEM","IE00BLSP4452.SGD","LU1894683264.USD","SG9999011175.SGD","LU0321505868.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","LU0868494617.USD","LU1894683348.USD","IE00B3T34201.USD","BK4599","SG9999001176.USD","IE00BLSP4239.USD","LU0225284248.USD","LU0456855351.SGD","SG9999002232.USD","IE0002270589.USD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":5,"totalSize":272,"code":"91000000","status":"200"}]}}